We provide you with 20 years of free, institutional-grade data for EYEN stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of EYEN. Explore the full financial landscape of EYEN stock.
| Reported Date | CIK | Ticker | Type |
|---|
Eyenovia, Inc(NASDAQ:EYEN) 
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print (MAP) platform technology. The company focuses on to develop clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targe...
The information provided in this report about EYEN stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.